Form C-AR/A — Fisher Wallace Laboratories, Inc.
0001787792-26-000007 · filed Apr 30, 2026
https://fisherwallace.com
(possible website — auto-inferred, not verified)
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1787792
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 630 FLUSHING AVENUE, BOX 104
BROOKLYN, NY 11206 - Phone
- —
Most recent fiscal year financials
- Total assets
- $144,634
- Cash
- —
- Short-term debt
- $591,311
- Long-term debt
- $693,612
- Revenues
- $34,261
- COGS
- $5,049
- Taxes paid
- —
- Net income
- $-1,447,538
Same issuer's Form D filings
-
D · Jun 13, 2025$5M
View the original filing on SEC EDGAR ↗